An analysis of 1539 patients with cancer of unknown primary site
- 1 January 1986
- Vol. 57 (1) , 120-124
- https://doi.org/10.1002/1097-0142(19860101)57:1<120::aid-cncr2820570124>3.0.co;2-m
Abstract
A retrospective review of 1539 patients with cancer of unknown primary site seen at Yale-New Haven Hospital from 1922 to 1981 was performed. Information was obtained from the Tumor Registry. The method of diagnosis, patient characteristics, year of diagnosis, histologic features, treatment received, and survival were analyzed. The most common cell type was adenocarcinoma. Survival overall was poor, with a median survival of 5 months for the entire group. Age and year of diagnosis did not appear to significantly influence survival. Closer examination of a small subset of those patients with squamous cell carcinoma revealed a very high male:female ratio, possibly related to tobacco and alcohol abuse. Nearly 9% of these patients were found to have a history of one or more unrelated malignancies.This publication has 19 references indexed in Scilit:
- Metastatic adenocarcinoma of unknown primary site: Analysis of 245 patients seen at the johns hopkins hospital from 1965-1979Medical and Pediatric Oncology, 1982
- The CUP syndrome (carcinoma unknown primary)Cancer Treatment Reviews, 1981
- Metastases of undetermined sourceCurrent Problems in Cancer, 1979
- Unknown primary adenocarcinoma: incidence of overinvestigation and natural history.BMJ, 1979
- Identifying the Primary Site in Metastatic Cancer of Unknown OriginPublished by American Medical Association (AMA) ,1979
- Adenocarcinoma of unknown primary site: A clinico-pathological studyMedical and Pediatric Oncology, 1979
- In pursuit of the unknown primaryThe American Journal of Surgery, 1978
- Treatment of the patient with adenocarcinoma of unknown originCancer, 1972
- Metastatic cancer of unknown primary siteCancer, 1970
- Maximum utilization of the life table method in analyzing survivalJournal of Chronic Diseases, 1958